🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9707230

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9708392

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9708267

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707287

Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707220

Scopolamine for the treatment of depression and anxiety

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701718

Adenovirus serotype 26 and serotype 35 filovirus vaccines

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9695230

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envel

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688739

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683263

Detection and treatment of irritable bowel syndrome

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683269

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676857

Soluble engineered monomeric Fc

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676846

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676771

Compounds for inhibiting drug-resistant strains of HIV-1 integrase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670549

Gene expression signatures of neoplasm responsiveness to therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663521

Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663485

Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657066

Pseudomonas exotoxin A with less immunogenic B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657292

Compositions and methods for treating or preventing lupus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657269

Regulatory B cells (tBREGS) and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657096

Human domain antibodies against components of the human insulin-like growth factor (IGF) s

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650352

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649339

LAT adapter molecule for enhanced T-cell signaling and method of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9644216

Adeno-associated virus vectors for treatment of glycogen storage disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9644179

Use of PDL1 expressing cells to convert T cells into regulatory T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted